News

Filter

Infectious diseases

February 16, 2021
Antibody-based COVID-19 treatments work best in concert with immune cells
Findings involving antibody effector functions could help improve design of next-generation COVID-19 antibody drugs.
News Release
February 4, 2021
Human immune cells have natural alarm system against HIV
Drugs that trigger alarm could lead to new HIV therapies .
News Release, Video
January 29, 2021
‘It’s why we got into medicine’
Fierce sense of mission drives front-line workers as they treat COVID-19.
Outlook Magazine
January 20, 2021
For some, GI tract may be vulnerable to COVID-19 infection
People with Barrett’s esophagus have SARS-CoV-2 receptors in upper GI tract.
News Release
January 15, 2021
Rapid blood test identifies COVID-19 patients at high risk of severe disease
Measuring mitochondrial DNA could predict who will need ICU care, intubation.
News Release
January 15, 2021
COVID-19 impact on pregnant women focus of NIH grant
Study will evaluate testing access and if pregnant women with COVID-19 need specialized care.
News Release
December 15, 2020
COVID-19 patients at higher risk of death, health problems than those with flu
Data analysis offers comparison of the 2 viruses.
News Release
December 9, 2020
Toxin provides clues to long-term effects of diarrhea caused by E. coli
Bacteria change surface of human intestine to benefit themselves.
News Release
December 8, 2020
Bateman, Diamond, Hultgren named to National Academy of Inventors
School of Medicine scientists honored for innovation.
News Release
November 19, 2020
Young people with disabilities focus of COVID-19 testing grant
$5 million grant to fund saliva tests for students, teachers, staff in schools operated by Special School District of St. Louis County.
News Release
November 18, 2020
Lethal brain infections in mice thwarted by decoy molecule
Discovery of receptor, generation of decoy could help contain outbreaks of Venezuelan equine encephalitis virus.
News Release
November 13, 2020
Study: Respiratory failure in COVID-19 usually not driven by cytokine storm
Findings indicate anti-inflammatory drugs likely to benefit only a fraction of people with severe disease.
News Release
November 12, 2020
Fluvoxamine may prevent serious illness in COVID-19 patients
Antidepressant drug repurposed for patients with coronavirus infection.
News Release
November 3, 2020
Cornea appears to resist infection from novel coronavirus
Other viruses, such as Zika and herpes simplex, replicate in corneal tissue.
News Release
October 30, 2020
Washington University begins recruiting participants for phase 3 COVID-19 investigational vaccine clinical trial
News Release
October 16, 2020
Immune modulator drugs for COVID-19 focus of major NIH clinical trial
Phase 3 trial involves hospitalized patients with moderate to severe disease.
News Release
September 3, 2020
Global trial to test whether MMR vaccine protects front-line health-care workers against COVID-19
Vaccine may strengthen immune response to viral infections; trial to enroll up to 30,000 health-care workers .
News Release
August 31, 2020
Study provides insight on how to build a better flu vaccine
New approach enables scientists to see how immune system responds to vaccination.
News Release
August 28, 2020
COVID-19 disproportionately affects developmentally disabled
In great need of in-person supports, developmentally disabled are overlooked in pandemic-related decisions, experts say.
News Release
August 27, 2020
Identifying emerging diseases focus of new international collaboration
School of Medicine to become 1 of 10 sites under new Centers for Research in Emerging Infectious Diseases.
News Release
August 26, 2020
Washington University develops COVID-19 saliva test
Test is faster, simpler than nasal, oral swab tests and enables screening on a massive scale.
News Release
August 21, 2020
Nasal vaccine against COVID-19 prevents infection in mice
Nasal delivery produces more widespread immune response than intramuscular injection.
News Release
August 12, 2020
Drug development for severe respiratory diseases supported with $3.9 million grant
New drug candidate targets asthma, COPD, other progressive lung diseases.
News Release
August 11, 2020
Clinical trial focuses on reducing overactive immune response in COVID-19
FDA-approved drug for rare diseases of the complement system could help coronavirus patients.
News Release
August 11, 2020
Experimental COVID-19 vaccine prevents severe disease in mice
Vaccine prevents pneumonia, elicits high levels of protective antibodies.
News Release
August 10, 2020
Washington University, St. Louis County collaborate on COVID-19 survey
Project will involve testing of up to 5,000 county residents.
News Release
August 4, 2020
Boosting immune system a potential treatment strategy for COVID-19
Researchers find weakened, rather than hyperactive, immunity in response to virus.
News Release
July 27, 2020
Lab-created virus can help COVID-19 research, developers say
Source: U.S. News & World Report
July 21, 2020
COVID-19 vaccine trials to be conducted at Washington University, Saint Louis University
Vaccine trials to enroll about 3,000 area residents.
News Release
July 20, 2020
Lab-made virus mimics COVID-19 virus
Is safer to work with, can aid efforts to find drugs, vaccines.
News Release
July 9, 2020
Search for cure for common parasitic infection focus of $5.5 million NIH grant
Toxoplasma infection affects about 2 billion people globally.
News Release
July 9, 2020
Global wildlife surveillance could provide early warning for next pandemic
Experts propose decentralized system to monitor wildlife markets, other hot spots.
News Release
July 6, 2020
Study to examine social media’s effects on stress during COVID-19 pandemic
National Science Foundation grant funds analysis, Twitter-based interventions.
News Release
July 1, 2020
Effort to screen potential COVID-19 antiviral drugs underway
Researchers can submit potential antiviral molecules for screening.
News Release
June 25, 2020
Folding@home’s fight against COVID-19 enlists big tech, gamers, pro soccer
Over 4 million computers worldwide aiding coronavirus research.
News Release, Video
June 25, 2020
Neidorffs commit $5 million to honor distinguished clinicians
Gift to establish endowed professorships recognizing Robert C. Packman, John S. Daniels.
News Release